Clinical Trial Update: Dupilumab in the Treatment of Keloids [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dupilumab for the treatment of keloids has completed, according to a study update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Keloid | Phase 4 | Status: COMPLETED